IP Library Granted Patent US 12,215,234
Granted Patent B2
US 12,215,234 · App. 17/023,544 · Granted Feb 4, 2025

Process for the purification of methylene blue

Inventors: Ravishanker Kovi (Monroe Township, NJ); Jayaraman Kannappan (Vadodara, IN); Hemant Mande (Gujarat, IN); Dusanapudi Naga Venkata Raghavulu (Vadodara, IN)
Assignee: RK Pharma Solutions LLC
C09B21/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,215,234
App. No.
17/023,544
Granted
Feb 4, 2025
Kind
B2
Abstract

The present application provides method for producing methylene blue that includes the steps of providing a reaction mixture having one or more methylene blue intermediates; precipitating metal from the reaction mixture; and producing therefrom crude methylene blue. The crude may further be purified, resulting in methylene compounds having low impurities, preferably having a purity greater than about 97%, having Azure B impurity no greater than 2.5%, and/or a total metal content no greater than 77 ppm. Formulations containing such compounds are also provided.

Claims (28)

1. A method for producing methylene blue comprising:

a) providing a reaction mixture comprising one or more methylene blue intermediates;

b) reducing the metal content therein by precipitation during solvent extraction under basic conditions wherein the basic condition is between about pH 9 and about pH 11; to form a reaction mass;

c) producing crude methylene blue by further adjusting the pH of the reaction mass to an acidic pH with acid;

d) purifying the crude methylene blue by treatment with polar solvent to remove the impurity at 0.94 RRT;

e) producing methylene blue having purity greater than about 97% by repeating steps (b) and (c) followed by purification using water and THF; wherein, providing the reaction mixture comprises,

I. reacting N,N-dimethylaniline

N,N-dimethylaniline

with sodium nitrite in hydrochloric acid to obtain an in-situ nitroso compound;

nitroso compound

II. reducing the in-situ nitroso compound

nitroso compound

in the presence of zinc and hydrochloric acid to obtain in-situ p-amino-N,N-dimethyl aniline;

p-amino-N,N-dimethyl aniline

III. reacting the in-situ p-amino-N,N-dimethyl aniline

p-amino-N,N-dimethyl aniline

with sulfuric acid and zinc chloride in the presence of sodium thiosulfate pentahydrate, sodium dichromate, and aluminium sulphate octahydrate to obtain an in-situ thiosulfonic acid compound;

thiosulfonic acid compound

IV. treating the in-situ thiosulfonic acid compound

thiosulfonic acid compound

with another molecule of N,N-dimethylaniline in the presence of sodium dichromate and zinc chloride to yield an in-situ di-cyclic compound;

Di-cyclic compound

and

V. allowing the in-situ di-cyclic compound

Di-cyclic compound

to undergo a cyclisation reaction in the presence of manganese oxide to yield methylene blue crude;

Methylene blue crude.

2. The method of claim 1 , comprising purifying the methylene blue crude using a polar solvent comprising acetic acid to obtain methylene blue.

Assignments (3)
SECURITY INTEREST Recorded May 8, 2024
From: RK PHARMA INC.
To: CITIBANK, N.A.
Reel/Frame 067343/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2022
From: RK PHARMA SOLUTIONS LLC
To: RK PHARMA INC
Reel/Frame 060263/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2020
From: KOVI, RAVISHANKER; KANNAPPAN, JAYARAMAN; MANDE, HERMANT; RAGHAVULU, DUSANAPUDI NAGA VENKATA
To: RK PHARMA SOLUTIONS LLC
Reel/Frame 054756/0529 →
Priority Claims (1)
IN 201921038163 · Sep 21, 2019 · national
Continuity (1)
Related Publication 20220049102A1 · Feb 17, 2022
References Cited (2)
US 20160251325A1 · Sinclair · 2016 [cited by examiner]
WO WO2020250186A1 · 2020 [cited by examiner]